 Operational Risk and Immune SystemAlessandro Capocchi ()
Chapter Chapter 7 in Vulnerability and the Corporate Immune System, 2023, pp 129-151 from Springer Abstract: Abstract This chapter will focus on the relationship between the corporate immune system and value creation. The efficiency of the corporate immune system is fueled over time thanks to self-financing policies. Proper and improper self-financing represents the natural and physiological tool for strengthening the company’s immune defenses throughout the life and functioning of the company itself. An implicit assumption of any corporate self-financing policy is the company’s ability to operate in conditions of value creation. The creation of value is an essential condition for any self-financing policy. But how can the company guarantee itself functioning in conditions of value creation? The creation of value is not an issue of an economic nature. Value creation is closely linked to business operations and the business combination of production. Therefore, it is essential to address the issue of value creation by paying attention to the relationship between economic and technical efficiency. This relationship is well explored in this chapter. Keywords: Operational risk; Efficiency; Corporate immune system; Self-financing policies; Creation of value (search for similar items in EconPapers) There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-30254-1_7 Ordering information: This item can be ordered from DOI: 10.1007/978-3-031-30254-1_7 Access Statistics for this chapter More chapters in Springer Books from Springer |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.